COMMODORE CAPITAL
Commodore Capital is invested in the early stages of a major innovation cycle in biopharmaceuticals.
COMMODORE CAPITAL
Social Links:
Founded:
2019-01-01
Status:
Active
Contact:
(917) 970-1730
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail GoDaddy DNS Typekit
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-13 | Arkive | Commodore Capital investment in Seed Round - Arkive | 9.7 M USD |
| 2022-05-16 | Celcuity | Commodore Capital investment in Post-IPO Equity - Celcuity | 100 M USD |
| 2022-01-16 | Third Harmonic Bio | Commodore Capital investment in Series B - Third Harmonic Bio | 105 M USD |
| 2021-11-02 | Shoreline Biosciences | Commodore Capital investment in Series B - Shoreline Biosciences | 140 M USD |
| 2021-07-13 | Nimbus Therapeutics | Commodore Capital investment in Venture Round - Nimbus Therapeutics | 105 M USD |
| 2021-03-01 | Satsuma Pharmaceuticals | Commodore Capital investment in Post-IPO Equity - Satsuma Pharmaceuticals | 80 M USD |
| 2021-02-07 | Shoreline Biosciences | Commodore Capital investment in Series A - Shoreline Biosciences | 43 M USD |
| 2020-08-25 | Kronos Bio | Commodore Capital investment in Private Equity Round - Kronos Bio | 155 M USD |
| 2020-07-06 | Cogent Biosciences | Commodore Capital investment in Post-IPO Equity - Cogent Biosciences | 104.4 M USD |
| 2020-06-16 | C4 Therapeutics | Commodore Capital investment in Series B - C4 Therapeutics | N/A |
More informations about "Commodore Capital"
Commodore Capital - Crunchbase Investor Profile
Commodore Capital invests in late-stage biotechnology and healthcare companies, focusing on therapeutics. Their investment strategy is concentrated in North America, particularly in Massachusetts, California, and New York. Learn …See details»
Commodore Capital - Investments, Portfolio & Company Exits
Commodore Capital 's most notable exits include Spyre Therapeutics, Kronos Bio, and …See details»
Vanderbilt Commodore Capital Group
Vanderbilt University’s Premier Private Financial Markets Organization. CCG Placement. Our Mission. ... Commodore Capital Group. Any questions? Feel free to reach out to our Executive Team. 2301 Vanderbilt Place Nashville, TN, …See details»
Commodore Capital Investor Profile: Portfolio & Exits
Commodore Capital's latest investment was on 04-Nov-2024 in Neurogene, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most …See details»
COMMODORE CAPITAL LP Top 13F Holdings - WhaleWisdom.com
Commodore Capital is a hedge fund with 3 clients and discretionary assets under management …See details»
Commodore Capital - Investor Profile, Portfolio & Team - Tracxn
Oct 22, 2024 11 of Commodore Capital's portfolio companies have become public. Third …See details»
Commodore Capital - Funding, Financials, Valuation & Investors
Commodore Capital has raised a total of $648.4M in a single venture fund, Commodore Capital …See details»
Commodore Capital Group - LinkedIn
Commodore Capital Group | 131 followers on LinkedIn. The premier organization for students …See details»
Michael Kramarz, MD, MBA — Commodore Capital
Prior to founding Commodore, Michael was a medical products investor at Samlyn Capital, where he focused on small and mid-cap biopharma companies. While in graduate school, Michael worked for Celgene’s (acquired by Bristol …See details»
Commodore Capital L.P. 13F annual report (2024) | wallmine
$622 million Assets Under Management (AUM) As of 7th November 2022, Commodore Capital …See details»
COMMODORE CAPITAL Portfolio and News - GuruFocus
Sep 30, 2024 COMMODORE CAPITAL . In addition to sector and industry breakdowns, there …See details»
COMMODORE CAPITAL LP Acquires New Stake in Vistagen …
On August 7, 2023, COMMODORE CAPITAL LP (Trades, Portfolio) purchased 1,575,000 …See details»
Application Information — Vanderbilt Commodore Capital Group
Commodore Capital Group is Vanderbilt’s first student organization dedicated to the private …See details»
Egen Atkinson, MD, MBA — Commodore Capital
Egen Atkinson is a Co-Founder and Managing Partner of Commodore Capital. Prior to …See details»
Commodore Capital 13F filings and top holdings and stakes
Past Filings by Commodore Capital . SEC 13F filings are viewable for Commodore Capital …See details»
Commodore Capital - Contacts, Employees, Board Members
Commodore Capital has 3 current employee profiles, including Co-Founder & Managing …See details»
Commodore Capital Fund: Performance - PitchBook
Aug 24, 2020 Commodore Capital Fund's latest investment was on 02-Nov-2021 in Shoreline …See details»
Lisa Schechner - Commodore Capital
Lisa Schechner is a biotechnology investor at Commodore Capital. Prior to joining …See details»
Commodore Capital Lp 13F Portfolio - HedgeFollow
Hedge Fund Portfolio Manager Performance 24Q2 AUM # of Holdings Performance Rank …See details»